Early experience of a multicentre phase I/II study of hypofractionated radiotherapy (55Gy/16 fractions/4 weeks) for localized prostate cancer

被引：0
|
作者：
Wu, J.
Skarsgard, D.
Pearcey, R.
Cadman, P.
Murray, B.
Newcomb, C.
机构：
[1] Tom Baker Canc Clin, Radiat Therapy Program, Calgary, AB, Canada
[2] Saskatoon Canc Ctr, Saskatoon, SK, Canada
[3] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：244 / 244
页数：1
相关论文
共 50 条
  • [1] Early experience of a multicentre phase I/II study of hypofractionated radiotherapy (55 Gy/16 fractions/4 weeks) for localized prostate cancer
    Wu, J
    Skarsgard, D
    Pearcey, R
    Cadman, P
    Murray, B
    Newcomb, C
    RADIOTHERAPY AND ONCOLOGY, 2005, 76 : S37 - S37
  • [2] Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions
    Ermis, Ekin
    Teo, Mark
    Dyker, Karen E.
    Fosker, Chris
    Sen, Mehmet
    Prestwich, Robin J. D.
    RADIATION ONCOLOGY, 2015, 10
  • [3] Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions
    Ekin Ermiş
    Mark Teo
    Karen E. Dyker
    Chris Fosker
    Mehmet Sen
    Robin JD Prestwich
    Radiation Oncology, 10
  • [4] Phase II study of hypofractionated image-guided radiotherapy for localized prostate cancer: Outcomes of 55 Gy in 16 fractions at 3.4 Gy per fraction
    Wu, Jackson S. Y.
    Brasher, Penelope M. A.
    El-Gayed, All
    Pervez, Nadeem
    Tai, Patricia T.
    Robinson, John
    Skarsgard, David
    Joseph, Kurian
    Sia, Michael A.
    Pearcey, Robert G.
    RADIOTHERAPY AND ONCOLOGY, 2012, 103 (02) : 210 - 216
  • [5] Late toxicity data for hypofractionated (55Gy in 20 fractions) radical external beam conformal radiotherapy to the prostate
    Cardale, J.
    Henry, A.
    Kiltie, A.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S450 - S451
  • [6] 4-Year Outcomes of Hypofractionated Image-Guide Radiotherapy (55 Gy/16 fractions/4 weeks) for Low and Intermediate Risk Prostate Cancer: A Multicenter Study
    Wu, J. S.
    Skarsgard, D.
    El-Gayed, A.
    Pervez, N.
    Tai, P.
    Brasher, P.
    Sia, M.
    Robinson, J. W.
    Joseph, K.
    Pearcey, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S188 - S189
  • [7] MULTICENTRE PHASE I/II STUDY OF HYPO-FRACTIONATED IMAGE-GUIDED RADIOTHERAPY (55 GY/16 FRACTIONS/4 WEEKS) FOR LOW AND INTERMEDIATE RISK PROSTATE CANCER: TOXICITY REPORT AT 24-MONTH FOLLOW-UP
    Wu, J. S. Y.
    El-Gayed, A.
    Pervez, N.
    Tai, P.
    Skarsgard, D.
    Sia, M.
    Brasher, P.
    Joseph, K.
    Pearcey, R.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S30 - S31
  • [8] IMAGE-GUIDED HYPOFRACTIONATED RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER WITH 42 GY IN 7 FRACTIONS: RADIOBIOLOGY AND PRELIMINARY CLINICAL RESULTS OF A PHASE-II STUDY
    Magli, Alessandro
    Ceschia, Tino
    Titone, Francesca
    Isola, Miriam
    Vavassori, Vittorio
    Malisan, Maria Rosa
    Fongione, Sandro
    ANTICANCER RESEARCH, 2015, 35 (06) : 3644 - 3646
  • [9] Adverse late effects in a prospective phase I-II trial of hypofractionated radiotherapy (66Gy/22 fractions) for localized adenocarcinoma of the prostate
    Sia, M.
    Menard, C.
    Rosewall, T.
    Bayley, A.
    Bristow, R.
    Chung, P.
    Crook, J.
    Gospodarowicz, M.
    McLean, M.
    Milosevic, M.
    Warde, P.
    Catton, C.
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S70 - S71
  • [10] Ten -Year Outcomes of Hypofractionated (45 Gy in 9 Fractions) Intensity Modulated Radiotherapy for Localized Prostate Cancer
    Zhong, S.
    Liu, Y.
    Fang, H.
    Tang, P.
    Dai, J.
    Shou, J.
    Li, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E455 - E456
12345